British Association for Psychopharmacology releases treatment guidelines for sleep disorders
The British Association for Psychopharmacology has authored new guidelines to help psychiatrists and physicians treat and diagnose people with sleep problems.
Members of the association met with clinicians and sleep disorder experts from the United States and Europe to develop a consensus statement on evidence-based treatments for sleep and circadian rhythm disorders.
The guidelines will be published and featured in the Journal of Psychopharmacology. It contains sleep disorder treatments for chronic insomnia.
“Stress, life changes, a new baby or shift work are typical factors that can trigger insomnia, but for some people this acute insomnia persists into a chronic state,” said the authors in a statement. “Anxiety about sleep, maladaptive sleep habits and the possibility of an underlying vulnerability in sleep regulating mechanisms are all likely causes, as are other co-morbid disorders such as anxiety and depression and diseases including cancer or arthritis.”
